Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$958M |
| 2 |
Pinduoduo
PDD
|
+$645M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$584M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$528M |
| 5 |
GE Aerospace
GE
|
+$516M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.51B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.37B |
| 3 |
Apple
AAPL
|
+$1.18B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$835M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$650M |
Sector Composition
| 1 | Technology | 20.8% |
| 2 | Financials | 10.05% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Healthcare | 8.58% |
| 5 | Industrials | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4376
Athira Pharma
ATHA
$15M
| $110K | ﹤0.01% |
+40,051
| New | +$110K |
|
4377
Aveanna Healthcare
AVAH
$1.73B
| $109K | ﹤0.01% |
43,752
-2,238
| -5% | -$5.57K |
|
4378
Mobix Labs
MOBX
$57.1M
| $109K | ﹤0.01% |
54,023
+41,576
| +334% | +$83.6K |
|
|
SCRMU
4379
DELISTED
Screaming Eagle Acquisition Corp. Unit
SCRMU
| $108K | ﹤0.01% |
+10,000
| New | +$108K |
|
4380
Personalis
PSNL
$478M
| $108K | ﹤0.01% |
72,373
-21,671
| -23% | -$32.3K |
|
4381
Pulse Biosciences
PLSE
$994M
| $106K | ﹤0.01% |
+12,206
| New | +$106K |
|
4382
Crexendo
CXDO
$194M
| $105K | ﹤0.01% |
+21,860
| New | +$105K |
|
4383
United Security Bancshares
UBFO
$166M
| $105K | ﹤0.01% |
13,580
-10,638
| -44% | -$82K |
|
4384
Iris Energy
IREN
$9.15B
| $104K | ﹤0.01% |
19,321
-97,600
| -83% | -$527K |
|
|
IMA
4385
ImageneBio, Inc. Common Stock
IMA
$99.6M
| $103K | ﹤0.01% |
6,050
+4,084
| +208% | +$69.6K |
|
4386
Lifezone Metals Limited Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
LZM.WS
$31.6M
| $102K | ﹤0.01% |
156,400
| – | – |
|
4387
Achieve Life Sciences
ACHV
$168M
| $101K | ﹤0.01% |
+22,218
| New | +$101K |
|
|
USAS
4388
Americas Gold and Silver
USAS
$745M
| $101K | ﹤0.01% |
183,575
+161,814
| +744% | +$89K |
|
4389
Applied DNA Sciences
APDN
$3.36M
| $99.5K | ﹤0.01% |
+1
| New | +$99.5K |
|
4390
Lazydays
GORV
$8.29M
| $98.5K | ﹤0.01% |
814
-893
| -52% | -$108K |
|
|
UROY
4391
Uranium Royalty Corp
UROY
$438M
| $97.2K | ﹤0.01% |
+40,671
| New | +$97.2K |
|
4392
Gores Guggenheim
PSNY
$2.02B
| $96.8K | ﹤0.01% |
62,828
-15,428
| -20% | -$23.8K |
|
|
NB
4393
NioCorp Developments
NB
$327M
| $93.5K | ﹤0.01% |
34,387
+95
| +0.3% | +$258 |
|
4394
Marchex
MCHX
$88.4M
| $93.1K | ﹤0.01% |
67,929
+2
| +0% | +$3 |
|
4395
Torrid Holdings
CURV
$179M
| $92.4K | ﹤0.01% |
18,925
+479
| +3% | +$2.34K |
|
4396
AN2 Therapeutics
ANTX
$33.6M
| $92.2K | ﹤0.01% |
28,370
+14,324
| +102% | +$46.6K |
|
4397
OppFi
OPFI
$289M
| $92.1K | ﹤0.01% |
36,846
+11,497
| +45% | +$28.7K |
|
|
NEXN
4398
Nexxen International
NEXN
$606M
| $92K | ﹤0.01% |
17,622
-1,459
| -8% | -$7.62K |
|
|
DNMR
4399
DELISTED
Danimer Scientific, Inc.
DNMR
| $91.9K | ﹤0.01% |
2,108
-9,263
| -81% | -$404K |
|
4400
WM Technology
MAPS
$131M
| $91.3K | ﹤0.01% |
68,650
| – | – |
|